Skip to content

Cognitive rehabilitation for patients with OCD

Evaluation of efficacy for group-therapy of a package based on Goal Management Training and Metacognitive Therapy among patients with obsessive-compulsive disorder for improving cognitive functions and reducing symptoms severity

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170123032145N8
Enrollment
36
Registered
2025-01-19
Start date
2025-04-05
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-compulsive disorder. Obsessive-compulsive disorder

Interventions

Intervention 1: Intervention group: The initial three of the eight sessions will focus on metacognitive therapy, and the last five will focus on goal management training. Each session will last two ho

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who meet DSM-5 criterion for OCD and they achieve more than 21 for Yale-Brown Obsessive Compulsive Scale are suitable for study.They should be 18-65 year old. They should sign the consent form. have been on a stable dose of OCD medication for a minimum of 8 weeks before the study, if applicable.

Exclusion criteria

Exclusion criteria: (1) concurrently meet DSM-5-TR criteria for a severe mood disorder, substance abuse/dependence (other than nicotine and caffeine), schizophrenia, or other psychotic disorders; (2) have a organic impairment or suspected organic pathology; (3) have active medical comorbidity that might require necessary intervention during the trial; (4) have a history of medical disorders known to significantly affect cognition (such as heart disease) in the past year; (5) have a history of traumatic brain injury, loss of consciousness, or concussion; (6) receive treatments known to significantly affect cognition (such as anticholinergic agents or receiving electroconvulsive therapy within the past 6 months)

Design outcomes

Primary

MeasureTime frame
Severity of obsessive-compulsive disorder. Timepoint: Months: 0,2,5. Method of measurement: Yale-Brown Obsessive Compulsive Scale(YBOCS).;Neurocognitive Functions. Timepoint: Months: 0,2,5. Method of measurement: Conners’ Continuous Performance Task , The Stroop Color and Word Test , The Tower of London, The California Verbal Learning Test , The Wechsler Test of Adult Reading.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammadreza Shalbafan

Iran University of Medical Sciences

shalbafan.mr@iums.ac.ir+98 21 86701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026